VDAC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.06694686208675E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.35610000018671E-07 |
Normal-vs-Stage2 |
9.77549999999772E-05 |
Normal-vs-Stage3 |
2.88435941797616E-13 |
Normal-vs-Stage4 |
9.11270000014675E-07 |
Stage1-vs-Stage2 |
9.267200E-01 |
Stage1-vs-Stage3 |
3.71580000000371E-05 |
Stage1-vs-Stage4 |
3.159200E-01 |
Stage2-vs-Stage3 |
8.556700E-03 |
Stage2-vs-Stage4 |
5.073800E-01 |
Stage3-vs-Stage4 |
4.219500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.87300175369387E-11 |
Normal-vs-AfricanAmerican |
1.37749999995496E-06 |
Normal-vs-Asian |
9.315500E-03 |
Caucasian-vs-AfricanAmerican |
8.369200E-01 |
Caucasian-vs-Asian |
5.290400E-01 |
AfricanAmerican-vs-Asian |
5.752200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.96429555848954E-11 |
Normal-vs-Female |
1.64650004741418E-09 |
Male-vs-Female |
5.756200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.483320E-03 |
Normal-vs-Age(41-60Yrs) |
2.8872015889192E-11 |
Normal-vs-Age(61-80Yrs) |
2.46719999985601E-09 |
Normal-vs-Age(81-100Yrs) |
2.002500E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.575000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.894200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.298200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.008600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.267400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.697000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.604810E-01 |
Normal-vs-Grade 2 |
1.20680000004203E-06 |
Normal-vs-Grade 3 |
1.17690301948414E-11 |
Normal-vs-Grade 4 |
2.67440003476338E-09 |
Grade 1-vs-Grade 2 |
2.405000E-01 |
Grade 1-vs-Grade 3 |
4.412000E-02 |
Grade 1-vs-Grade 4 |
2.724000E-02 |
Grade 2-vs-Grade 3 |
1.735430E-03 |
Grade 2-vs-Grade 4 |
4.161700E-03 |
Grade 3-vs-Grade 4 |
4.423600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.2277000000237E-06 |
Normal-vs-ccB subtype |
8.3428819408482E-12 |
ccA subtype-vs-ccB subtype |
1.430370E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.72829561562571E-11 |
Normal-vs-N1 |
5.765600E-04 |
N0-vs-N1 |
4.409600E-01 |
|
|